The BASG has no clinical data on the medical effects of products marketed under the designation "GLP-1"
Huberman explores is BPC-157, a peptide that has garnered attention for its tissue-repair properties
5 7 Absence of definitive head-to-head superiority trials
The researchers concluded that PC1031 had a comparable effect to that of topical minoxidil, an FDA-approved hair growth treatment [7]
Administration of CCK, in humans and animals, inhibits food intake by reducing meal size and its duration.17,18 Recent work suggests that CCK-A receptors expressed by vagal afferent neurons are an important target for CCK in producing sensations of satiety, as well as inhibiting gastric emptying and stimulating pancreatic digestive enzyme secretion.19 In animals it is thought that the reduction in food intake may be mediated by a paracrine/neurocrine effect since high concentrations of CCK occur only locally to the site of release.20 Thus, locally released CCK may increase vagal tone, without a significant increase in plasma CCK level
Behavioral Support: Engaging in strategies that address emotional eating, stress management, and consistent adherence to your treatment plan